Sign in

CIK 0001817241 · <br>Emerging growth company

Artiva Biotherapeutics, Inc.

Sign in to watch
Ticker
ARTV
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
863614316
Phone
(858) 267-4467
Business address
5505 MOREHOUSE DRIVE, SAN DIEGO, CA, 92121
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,341,159
in 16 filings, $529K under 10b5-1 plans

Net −$2,341,159. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Aslan Fred −$1.8M Chief Executive Officer sold 14% of stake
  2. Horan Christopher −$230K Chief Tech Operations Officer sold 9% of stake
  3. Bush Jennifer −$186K COO, CLO, Compliance Officer sold 7% of stake
  4. Banerjee Subhashis −$128K Chief Medical Officer sold 7% of stake
Date Insider Transaction Shares Price Value Owned after
2026-06-15 RA CAPITAL MANAGEMENT, L.P. Director Purchase +15,414 $8.99 $139K 16,638,150
2026-06-12 RA CAPITAL MANAGEMENT, L.P. Director Purchase +391,019 $8.57 $3.4M 16,622,736
2026-06-11 RA CAPITAL MANAGEMENT, L.P. Director Purchase +548,580 $7.91 $4.3M 16,231,717
2026-06-10 RA CAPITAL MANAGEMENT, L.P. Director Purchase +103 $7.00 $721 15,683,137
2026-06-09 RA CAPITAL MANAGEMENT, L.P. Director Purchase +479,039 $6.91 $3.3M 15,683,034
2026-05-19 Raymon Heather SVP, Research and Development Sale −3,095 $9.01 $28K 148,228
2026-05-19 Horan Christopher Chief Tech Operations Officer Sale −7,002 $9.01 $63K 293,450
2026-05-19 Bush Jennifer COO, CLO, Compliance Officer Sale −8,790 $9.01 $79K 337,920
2026-05-19 Banerjee Subhashis Chief Medical Officer Sale −7,037 $9.01 $63K 144,963
2026-05-19 Aslan Fred Chief Executive Officer Sale −27,116 $9.01 $244K 1,535,082
2026-05-18 Miralles Gines Diego President & Head of R&D Grant or award +77,500 77,500
2026-05-18 Miralles Gines Diego President & Head of R&D Grant or award · Employee Stock Option (Right to Buy) +232,500 232,500
2026-05-11 GC Corp. 10% owner Purchase +1,085,069 $11.52 $12.5M 4,391,969
2026-05-11 GC Corp. 10% owner Purchase +347,222 $11.52 $4.0M 1,607,734
2026-05-11 RA CAPITAL MANAGEMENT, L.P. Director Purchase +6,510,416 $11.52 $75.0M 15,203,995
2026-05-11 RA CAPITAL MANAGEMENT, L.P. Director Purchase · Pre-Funded Warrant (Right to Buy) +2,170,138 $11.52 $25.0M 2,170,138
2026-03-10 Huston Thad Allen Chief Financial Officer Grant or award +220,000 220,000
2026-02-18 Sorg Elaine K. Director Grant or award · Director Stock Option (Right to Buy) +27,500 27,500
2026-02-15 Raymon Heather SVP, Research and Development Grant or award +46,000 152,844
2026-02-15 Raymon Heather SVP, Research and Development Shares withheld for taxes −1,521 $4.00 $6K 151,323

Page 4 of 11 · 203 trades